Forum Financial Management LP Makes New Investment in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Forum Financial Management LP acquired a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,519 shares of the pharmacy operator’s stock, valued at approximately $103,000.

A number of other large investors also recently modified their holdings of WBA. Capital World Investors raised its position in Walgreens Boots Alliance by 57.5% in the 1st quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after buying an additional 10,612,373 shares during the last quarter. Thompson Siegel & Walmsley LLC raised its holdings in shares of Walgreens Boots Alliance by 98.8% in the second quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after purchasing an additional 2,992,648 shares during the last quarter. Newport Trust Company LLC bought a new position in shares of Walgreens Boots Alliance during the second quarter valued at about $31,028,000. Swedbank AB purchased a new position in Walgreens Boots Alliance during the first quarter worth about $16,365,000. Finally, Minneapolis Portfolio Management Group LLC purchased a new stake in Walgreens Boots Alliance in the 1st quarter valued at about $13,710,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 3.1 %

Shares of NASDAQ WBA opened at $9.62 on Wednesday. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The company has a market cap of $8.32 billion, a P/E ratio of -0.96, a P/E/G ratio of 1.24 and a beta of 0.69. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The business has a 50-day simple moving average of $9.19 and a two-hundred day simple moving average of $12.32.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. During the same period last year, the business earned $0.67 earnings per share. Walgreens Boots Alliance’s revenue was up 5.9% compared to the same quarter last year. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.40%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on WBA. Jefferies Financial Group reduced their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Truist Financial lowered their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. UBS Group increased their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Bank of America reduced their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.